Top Markets
Coin of the day
ObsEva S.A. ObsEva S.A.

ObsEva S.A.

OBSN
Classificação em ações #40302
ObsEva S.A. is a biopharmaceutical company focused on developing and... ObsEva S.A. is a biopharmaceutical company focused on developing and commercializing groundbreaking therapies for women facing challenges in reproductive health and pregnancy. Its product pipeline includes Linzagolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist currently in Phase III clinical trials. Linzagolix is being evaluated for its efficacy in treating pain associated with endometriosis and heavy menstrual bleeding linked to uterine fibroids in pre-menopausal women. The firm is also progressing with Ebopiprant, an oral and selective prostaglandin F2a (PGF2a) receptor antagonist, which is in Phase II clinical trials as a once-daily treatment for preterm labor occurring between 24 and 34 weeks of gestational age. Additionally, ObsEva is developing Nolasiban, an oral oxytocin receptor antagonist in Phase I clinical trials, aimed at enhancing clinical pregnancy and live birth rates for women undergoing in vitro fertilization. ObsEva S.A. was founded in 2012 and maintains its headquarters in Geneva, Switzerland.
Preço da ação
$0.00156067
Última sincronização: 2024-05-03
Valor de mercado
$182.87K
Variação (1 dia)
-72.69%
Variação (1 ano)
0.00%
País
CH
Negociar ObsEva S.A. (OBSN)

Categoria

Histórico de preços das ações de ObsEva S.A. (OBSN)
Preço de fecho mais alto: $0.00 em 2024-05-01

Preço de fecho mais baixo: $16.22 em 2018-07-01
Histórico de preços das ações da ObsEva S.A. de 2018 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 -92.05%
2023 -71.26%
2022 -92.71%
2021 1.17%
2020 -41.38%
2019 -73.99%
2018 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.08K -5.43%
KR
$259.89 14.81%
BE